Here is a high-quality, comprehensive, and easy-to-read analysis/report on this company in a very interesting “situation.” 
Biohit is focused on diagnostics of the gastrointestinal tract and health-promoting products. The company has achieved a successful turnaround and is targeting strong growth of 15-20% over the 2024-28 strategy period. We expect the company’s earnings to continue to grow in the coming years, supported by the development of new markets and the introduction of new products.
